Metrika članka

  • citati u SCindeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[=>]
  • posete u poslednjih 30 dana:10
  • preuzimanja u poslednjih 30 dana:5
članak: 1 od 5  
Back povratak na rezultate
Vojnosanitetski pregled
2018, vol. 75, br. 9, str. 864-874
jezik rada: engleski
vrsta rada: izvorni naučni članak
doi:10.2298/VSP160905008Z

Creative Commons License 4.0
Kvalitet života posle mehaničke ventilacije kod bolesnika lečenih od pneumonije
aUniversity of Kragujevac, Faculty of Medical Sciences, Clinical Center 'Kragujevac', Department for Anesthesiology and Reanimation
bUniversity of Kragujevac, Faculty of Medical Sciences, Clinical Center 'Kragujevac', Department for Clinical Pharmacology
cUniversity of Kragujevac, Faculty of Medical Sciences, Clinical Center 'Kragujevac', Clinic for Nephrology and Urology
dUniversity of Kragujevac, Faculty of Medical Sciences, Clinical Center 'Kragujevac', Clinic for Surgery
eUniversity of Kragujevac, Faculty of Medical Sciences, Clinical Center 'Kragujevac', Clinic for Cardiology
fUniverzitet u Beogradu, Medicinski fakultet, Institut za medicinsku statistiku i informatiku
gUniversity of Kragujevac, Faculty of Medical Sciences, Clinical Center 'Kragujevac', Department of Psychiatry
hMilitary Medical Academy, Department of Thoracic Surgery
iUniversity of Kragujevac, Faculty of Medical Sciences, Clinical Center 'Kragujevac', Department for Histology

e-adresa: nenadzornic@gmail.com

Projekat

Farmakološka analiza efekata biološki aktivnih supstanci na izolovane glatke mišiće gastrointestinalnog i urogenitalnog trakta čoveka (MPNTR - 175007)

Sažetak

Uvod/Cilj. Bolesnici sa pneumonijom koji zahtevaju mehaničku ventilaciju (MV) povezani su sa nekoliko loših ishoda, kao što su produžena hospitalizacija, veća stopa smrtnosti i povećano širenje patogena otpornih na antibiotike. MV kod bolesnika sa vanbolnički stečenom pneumonijom (community-acquired pneumonia - CAP) može izazvati razvoj psihološke simptomatologije, koje su često zanemarene u jedinicama intenzivnog lečenja (JIL), i smanjenjem kvaliteta života nakon prestanka MV. Cilj studije je bio da se proceni kvalitet života kod bolesnika sa CAP koji se leče primenom MV u JIL. Metode. Istraživanje je sprovedeno u obliku studije koja je obuhvatala hospitalizovane zbog CAP. Kvalitet života definisan je kao primarni ishod, dok je primena MV pretpostavljena kao primarni prognostički faktor koji negativno utiče na ishod. Bolesnici su regrutovani iz populacije bolesnika sa CAP koje su bile hospitalizovane u JIL u Kliničkom centru Kragujevac, Srbija, od januara 2013. do januara 2014. godine. Eksperimentalna grupa sastojala se od bolesnika koji su bili na MV, a kontrolna grupa bili su bolesnici sa CAP, kiji nisu bili podvrgnuti MV. Kvalitet života procenjen je pomoću EuroQoL Group-EQ-5D indeksa. Izračunavanje ukupne vrednosti EQ-5D-5L izvršeno je korišćenjem unapred definisanog, validiranog kartografskog ključa, u skladu sa kombinacijama odgovora. Statistička analiza obavljena je korišćenjem χ2 testa, Studentovog t-testa, univarijantne i multivariantne logističke regresione analize. Rezultati. Bolesnici sa MV imali su lošije vrednosti EQ5D-5L u poređenju sa kontrolnom grupom za svih pet domena. Mobilnost, samozbrinjavanje i uobičajene aktivnosti bili su najlošije ocenjeni tokom čitavog perioda praćenja. Bol ili neugodnost i anksioznost ili depresija značajno su se razlikovali između studijske i kontrolne grupe u sedmom i tridesetom danu lečenja. Zaključak. Bolesnici sa MV imaju slabiji kvalitet života, naročito u tri domena. Glavni razlozi su prisustvo hroničnih komorbiditeta kod populacije koja zahteva primenu MV.

Ključne reči

Reference

Allin, D., James, I., Zachariah, J., Carr, W., Cullen, S., Middleton, A., Newson, P., Lytle, T., Coles, S. (2001) Comparison of once- and twice-daily clarithromycin in the treatment of adults with severe acute lower respiratory tract infections. Clinical Therapeutics, 23(12): 1958-1968
Alonso, J., Ferrer, M., Gandek, B., Ware, J.E., Aaronson, N.K., Mosconi, P., Rasmussen, N.K., Bullinger, M., Fukuhara, S., Kaasa, S., Leplège, A. (2004) Health-related quality of life associated with chronic conditions in eight countries: Results from the International Quality of Life Assessment (IQOLA) Project. Quality of Life Research, 13(2): 283-298
Bhargava, S., Prakash, A., Rehan, H.S., Gupta, L.K. (2015) Effect of systemic corticosteroids on serum apoptotic markers and quality of life in patients with asthma. Allergy and Asthma Proceedings, 36(4): 275-282
Bordon, J., Aliberti, S., Fernandez-Botran, R., Uriarte, S.M., Rane, M.J., Duvvuri, P., Peyrani, P., Morlacchi, L.C., Blasi, F., Ramirez, J.A. (2013) Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia. International Journal of Infectious Diseases, 17(2): e76-e83
Burnham, E.L., Hyzy, R.C., Paine, R., Coley, C., Kelly, A.M., Quint, L.E., Lynch, D., Janssen, W.J., Moss, M., Standiford, T.J. (2013) Chest CT Features are Associated With Poorer Quality of Life in Acute Lung Injury Survivors*. Critical Care Medicine, 41(2): 445-456
Busico, M., Intile, D., Sívori, M., Irastorza, N., Alvarez, A.L., Quintana, J., Vazquez, L., Plotnikow, G., Villarejo, F., Desmery, P. (2016) Risk factors for worsened quality of life in patients on mechanical ventilation. A prospective multicenter study. Medicina Intensiva (English Edition), 40(7): 422-430
Date, R.S., Walton, S.Y., Ryan, N., Rahman, S.N., Henley, N.C. (2013) Is selection bias toward super obese patients in the rationing of metabolic surgery justified?—A pilot study from the United Kingdom. Surgery for Obesity and Related Diseases, 9(6): 981-986
Dhar, R. (2012) Pneumonia: review of guidelines. J Assoc Physicians India, 25-8; 60, Suppl
Dupont, W.D., Plummer, W.D. (1990) Power and sample size calculations. Controlled Clinical Trials, 11(2): 116-128
el Moussaoui, R., Opmeer, B.C., de Borgie, C.A.J.M., Nieuwkerk, P., Bossuyt, P.M.M., Speelman, P., Prins, J.M. (2006) Long-term Symptom Recovery and Health-Related Quality of Life in Patients With Mild-to-Moderate-Severe Community-Acquired Pneumonia. Chest, 130(4): 1165-1172
Euteneuer, S., Windisch, W., Suchi, S., Köhler, D., Jones, P.W., Schönhofer, B. (2006) Health-related quality of life in patients with chronic respiratory failure after long-term mechanical ventilation. Respiratory Medicine, 100(3): 477-486
Falk, H.M., Brinth, L.S., Olesen, A.V., Petersen, K.D., Ehlers, L. (2015) The Health-Related Quality of Life for Patients with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS). PLOS ONE, 10(7): e0132421
File, T.M., Marrie, T.J. (2010) Burden of Community-Acquired Pneumonia in North American Adults. Postgraduate Medicine, 122(2): 130-141
Flamaing, J., de Backer, W., van Laethem, Y., Heijmans, S., Mignon, A. (2015) Pneumococcal lower respiratory tract infections in adults: an observational case-control study in primary care in Belgium. BMC Family Practice, 16(1):
Garcia, G.S., Quintana, J.M., Baricot, M., Bilbao, A., Capelastegui, A., Cilla, E.C.G., Domínguez, A., Castilla, J., Godoy, P., Delgado-Rodríguez, M., Soldevila, N., Astray, J., Mayoral (2013) Predictive factors of severe multilobar pneumonia and shock in patients with influenza. Emergency Medicine Journal, 31(4): 301-307
Hamel, M.B., Phillips, R.S., Davis, R.B., Teno, J., Connors, A.F., Desbiens, N., Lynn, J., Dawson, N.V., Fulkerson, W., Tsevat, J. (2000) Outcomes and cost-effectiveness of ventilator support and aggressive care for patients with acute respiratory failure due to pneumonia or acute respiratory distress syndrome∗∗Access the “Journal Club” discussion of this paper at: http://www.ajmselect. American Journal of Medicine, 109(8): 614-620
Herdman, M., Gudex, C., Lloyd, A., Janssen, MF., Kind, P., Parkin, D., Bonsel, G., Badia, X. (2011) Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10): 1727-1736
Honselmann, K.C., Buthut, F., Heuwer, B., Karadag, S., Sayk, F., Kurowski, V., Thiele, H., Droemann, D., Wolfrum, S. (2015) Long-term mortality and quality of life in intensive care patients treated for pneumonia and/or sepsis. Journal of Critical Care, 30(4): 721-726
Isturiz, R.E., Luna, C.M., Ramirez, J. (2010) Clinical and economic burden of pneumonia among adults in Latin America. International Journal of Infectious Diseases, 14(10): e852-e856
Kempen, G.I., Ormel, J., Brilman, E.I., Relyveld, J. (1997) Adaptive responses among Dutch elderly: the impact of eight chronic medical conditions on health-related quality of life. American Journal of Public Health, 87(1): 38-44
Lima, M.G., Barros, M.B.de A., César, C.L.G., Goldbaum, M., Carandina, L., Ciconelli, R.M. (2009) Impact of chronic disease on quality of life among the elderly in the state of São Paulo, Brazil: a population-based study. Revista Panamericana de Salud Pública, 25(4):
López-Campos, J.L., Failde, I., Masa, J.F., Benítez-Moya, J.M., Barrot, E., Ayerbe, R., León-Jiménez, A. (2008) Factors related to quality of life in patients receiving home mechanical ventilation. Respiratory Medicine, 102(4): 605-612
Meier, T., Lange, A., Papenberg, H., Ziemann, M., Fentrop, C., Uhlig, U., Schmucker, P., Uhlig, S., Stamme, C. (2008) Pulmonary Cytokine Responses During Mechanical Ventilation of Noninjured Lungs With and Without End-Expiratory Pressure. Anesthesia & Analgesia, 107(4): 1265-1275
Mo, F., Choi, B.C.K., Li, F.C.K., Merrick, J. (2004) Using Health Utility Index (HUI) for Measuring the Impact on Health-Related Quality of Life (HRQL) Among Individuals with Chronic Diseases. Scientific World JOURNAL, 4: 746-757
Nickler, M., Schaffner, D., Christ-Crain, M., Ottiger, M., Thomann, R., Hoess, C., Henzen, C., Mueller, B., Schuetz, P. (2016) Prospective evaluation of biomarkers for prediction of quality of life in community-acquired pneumonia. Clinical Chemistry and Laboratory Medicine (CCLM), 54(11): 1831-46
Paulsen, Ø., Klepstad, P., Rosland, J.H., Aass, N., Albert, E., Fayers, P., Kaasa, S. (2014) Efficacy of Methylprednisolone on Pain, Fatigue, and Appetite Loss in Patients With Advanced Cancer Using Opioids: A Randomized, Placebo-Controlled, Double-Blind Trial. Journal of Clinical Oncology, 32(29): 3221-3228
Rolfson, O., Donahue, G.S., Hallsten, M., Garellick, G., Kärrholm, J., Nemes, S. (2016) Patient-Reported Outcomes in Cemented and Uncemented Total Hip Replacements. HIP International, 26(5): 451-457
Rosengarten, B., Krekel, D., Kuhnert, S., Schulz, R. (2012) Early neurovascular uncoupling in the brain during community acquired pneumonia. Critical Care, 16(2): R64
Sabbah, I., Drouby, N., Sabbah, S., Retel-Rude, N., Mercier, M. (2003) Quality of life in rural and urban populations in Lebanon using SF-36 health survey. Health and Quality of Life Outcomes, 1(1): 30
Sinđelić, R. (1998) Mechanical lund ventilation. Beograd: Medicinska knjiga
Song, J., Thamlikitkul, V., Hsueh, P. (2011) Clinical and economic burden of community-acquired pneumonia amongst adults in the Asia-Pacific region. International Journal of Antimicrobial Agents, 38(2): 108-17
Sprangers, M.A.G., Thong, M.S.Y., Bartels, M., Barsevick, A., Ordoñana, J., Shi, Q., Wang, X.S., Klepstad, P., Wierenga, E.A., Singh, J.A., Sloan, J.A. (2014) Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update. Quality of Life Research, 23(7): 1997-2013
Szende, A., Leidy, N.K., Ståhl, E., Svensson, K. (2009) Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D. Quality of Life Research, 18(2): 267-272
Tomasi, C.D., Vuolo, F., Generoso, J., Soares, M., Barichello, T., Quevedo, J., Ritter, C., Dal-Pizzol, F. (2017) Biomarkers of Delirium in a Low-Risk Community-Acquired Pneumonia-Induced Sepsis. Molecular Neurobiology, 54(1): 722-726
Torres, A., Peetermans, W.E., Viegi, G., Blasi, F. (2013) Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax, 68(11): 1057-1065
Tsevat, J. (2007) Health-related quality of life-an introduction. Am J Manag Care, 13 Suppl 9: S218-23
Tüzün, H., Aycan, S., İlhan, M.N. (2015) Impact of comorbidity and socioeconomic status on quality of life in patients with chronic diseases who attend primary health care centers. Cent Eur J Public Health, 23(3); 188-94
Walden, A.P., Clarke, G.M., McKechnie, S., Hutton, P., Gordon, A.C., Rello, J., Chiche, J., Stueber, F., Garrard, C.S., Hinds, C.J. (2014) Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept cohort. Critical Care, 18(2): R58
Welte, T., Torres, A., Nathwani, D. (2010) Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax, 67(1): 71-79
Wu, C., Chan, M., Chang, C., Lee, Y., Chin, C., Chang, K., Hsu, J. (2006) Etiology and Cytokine Expression in Patients Requiring Mechanical Ventilation Due to Severe Community-acquired Pneumonia. Journal of the Formosan Medical Association, 105(1): 49-55
Yoh, K., Hamaya, E., Urushihara, H., Iikuni, N., Yamamoto, T., Taketsuna, M., Miyauchi, A., Sowa, H., Tanaka, K. (2012) Quality of life in raloxifene-treated Japanese women with postmenopausal osteoporosis: a prospective, postmarketing observational study. Current Medical Research and Opinion, 28(11): 1757-1766
Zanchetti, A., Omboni, S., la Commare, P., de Cesaris, R., Palatini, P. (2001) Efficacy, Tolerability, and Impact on Quality of Life of Long-Term Treatment with Manidipine or Amlodipine in Patients with Essential Hypertension. Journal of Cardiovascular Pharmacology, 38(4): 642-650